Table 1 Study group characteristics
From: MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer
Patient group | Number of samples | Median age (min-max) | Median BMI (min-max) | % of postmenopausal | Average concentration of CA125 (U/mL) | Average concentration of HE4 (pmol/L) |
|---|---|---|---|---|---|---|
OC training set - Type I OC * borderline - Type II | 33 10 *5 23 | 57 (36–72) | 26.81 (17.29–38.37) | 23 (70%) | 2381.29 | 1025.10 |
OC test set - Type I OC * borderline - Type II | 11 3 *1 8 | 65 (32–78) | 24.75 (22.27–31.62) | 9 (82%) | 2177.67 | 1261.00 |
Control training set | 33 | 58 (19–73) | 26.06 (21.15–40.06) | 22 (67%) | not determined | not determined |
Control test set | 12 | 55 (31–63) | 27.56 (22.43–35.70) | 7 (58%) | not determined | not determined |